Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

November 05, 2018

News Daily News

螯合治疗：TACT2 试验为糖尿病传统 MI 后治疗提供前景

September 28, 2016

News Daily News

Más Quelación: Se Aprueba el Ensayo TACT2 para el Controvertido Tratamiento Post-IM en Pacientes Diabéticos

September 28, 2016

News Daily News

Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes

September 28, 2016

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

Importance of Optimal Reperfusion in Diabetic Patients Treated with Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Presentation TCT 2013

Importance of Optimal Reperfusion in Diabetic Patients Treated with Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Presenter: M.A. Velders, H. Boden, B.L. van der Hoeven, AACM Heestermans, VAWM Umans, SH Hofma, JW Jukema, M.J. Schalij, A. J. van Boven

January 31, 2013

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

November 04, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.